The non-therapeutic use of genes to enhance athletic performance (gene doping) is a novel threat to the World of Sports. Skeletal muscle is a prime target of gene therapy and we asked whether we can develop a test system to produce and detect gene doping. Towards this end, we introduced a plasmid (pCMV-FAK, 3.8 kb, 50 g) for constitutive expression of the chicken homologue for the regulator of muscle growth, focal adhesion kinase (FAK), via gene electro transfer in the anti-gravitational muscle, m. soleus, or gastrocnemius medialis of rats. Activation of hypertrophy signalling was monitored by assessing the ribosomal kinase p70S6K and muscle Wbre cross section. Detectability of the introduced plasmid was monitored with polymerase chain reaction in deoxyribonucleic acids (DNA) from transfected muscle and serum. Muscle transfection with pCMV-FAK elevated FAK expression 7-and 73-fold, respectively, and increased mean cross section by 52 and 16% in targeted muscle Wbres of soleus and gastrocnemius muscle 7 days after gene electro transfer. Concomitantly p70S6K content was increased in transfected soleus muscle (+110%). Detection of the exogenous plasmid sequence was possible in DNA and cDNA of muscle until 7 days after transfection, but not in serum except close to the site of plasmid deposition, 1 h after injection and surgery. The Wndings suggest that the reliable detection of gene doping in the immoral athlete is not possible unless a change in the current practice of tissue sampling is applied involving the collection of muscle biopsy close to the site of gene injection.
Introduction
Gene doping is a new threat to the world of sports which arose as a spin oV of gene therapy (Andersen et al. 2000; Filipp 2007; Sweeney 2004) . It is based on the introduction of genetic vectors into cells (transfection) which carry the message for the expression of transcripts and proteins. Today, this is feasible for a number of cell types, i.e. blood, liver, skeletal muscle, using viral and electroporation based approaches (Andre and Mir 2004; Gissel 2010) . Skeletal muscle is a particularly attractive host since the large muscle mass can be (ab)used for the local production of biological factors (Coelho-Castelo et al. 2006; Louz et al. 2005) . It is generally accepted that methods should be developed to prevent the abuse of this technology in Sports (Gassmann et al. 2005; Haisma and de Hon 2006) .
The WADA banns the use of gene doping based on the deWnition of 'the non-therapeutic use of genes, genetic eleCommunicated by Håkan Westerblad.
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The online version of this article (doi:10.1007/s00421-011-2113-y) contains supplementary material, which is available to authorized users. ments and/or cells that have the capacity to enhance athletic performance' (Unal and Ozer Unal 2004 ; http://www. wada-ama.org). The doping code speciWes that any biological material may be collected for the purposes of Doping Control (http://www.wada-ama.org). In reality, detection of gene doping will only be feasible in samples which can be collected based on accepted codes of practice such as urine and blood (Hartgens 2008) . A number of direct and indirect methods of detection have been proposed (Baoutina et al. 2010; Haisma and de Hon 2006; Mitchell et al. 2009 ). Polymerase chain reaction (PCR) is among the most sensitive technology that would allow detecting gene doping (Baoutina et al. 2010) . This is because it ampliWes deoxyribonucleic acids (DNA) sequences of the introduced genetic vector or encoded transcript after reverse transcription of RNA (Kubista et al. 2006) . SpeciWcity is directed by the selective binding of PCR oligonucleotides (primer) to the matching sequences in the sense and anti-sense strand of the DNA template which deWne the outer borders of the amplicon. The ampliWcation reaction bears the important advantage that the amount of the resulting amplicon is proportional to the initial DNA amount in the sample and lends itself to a quantitative evaluation through the use of an ampliWcation standard.
A number of biological processes oVer for the genetic enhancement of human performance. This includes DNAbased strategies to promote muscle growth via the activation of anabolic signal pathways (Striegel and Simon 2007) . This has been shown for a number of factors, i.e. AKT, Erythropoietin (Gassmann et al. 2005; Haisma and de Hon 2006) . Focal adhesion kinase (FAK) is part of the hypertrophy pathway which integrates hormonal and mechanical cues in a number of cell types, into the activation of the protein synthetic pathway Torsoni et al. 2003) . FAK-mediated signalling is regulated through the phosphorylation of tyrosine residue 397 (pY397) of FAK which reXects the initiation of the phosphotransfer activity of FAK and allows recruitment of downstream targets . The former posttranslational modiWcation occurs in response to mechanical loading and endocrine factors such as growth factors Rozengurt 1995; Shyy and Chien 1997) . Elevated pY397 content with increased loading of skeletal muscle precedes the phosphorylation of p70S6Kinase ) which upregulates ribosomal activity in a number of cell systems (Volarevic and Thomas 2001) . The implication of FAK-mediated activation of hypertrophy signalling is visualized in the increase of mean crosssectional area of muscle Wbres 7 days after transfection of anti-gravitational muscle by gene electro transfer with an expression construct for FAK ).
While the detection of genetic modiWcation has been shown for virus-mediated transfection of skeletal muscle with expression construct for the secreted hematopoietic factor erythropoietin (Beiter et al. 2011; Ni et al. 2011) it is unlikely that this transfection technology would be a method of choice. This is explained by various drawbacks including the induction of immune responses that reduce the success of repeated applications, the costs of production of GMO quality vectors and possibly fatal consequences due to the virulence of the approach (Raper et al. 2003) . In consequence, the possibilities for detection of gene doping by other means of transfection such as gene electrotransfer and net eVects of gene transfection on muscle structure and function are not explored.
We hypothesized that the introduction of a naked DNA vector in skeletal muscle is detectable in the serum of transfected animals as injected introduced plasmid may disseminates into the body (Coelho-Castelo et al. 2006 ). This was tested using established gene therapy for the ampliWcation of load-dependent hypertrophy signalling via overexpression of an exogenous FAK homologue from gallus gallus in rat soleus muscle from a constitutively active expression plasmid ). Exogenous and endogenous FAK sequence was quantiWed with PCR on isolated DNA using species-speciWc primer pairs. Results were validated against spiking controls and plasmid standard and measures after early time points of transfection.
Methods

Study design
Soleus and gastrocnemius muscle of 3-month-old male Wistar rats was transfected with expression plasmid for chicken FAK by gene electrotransfer. Blood and muscle samples were collected and DNA was extracted for ampliWcation with polymerase chain reaction using speciWc primers. In addition, muscle samples were processes for detection of FAK and muscle Wbre size in cryosections and p70S6K phosphorylation in immunoblots. Samples from non-transfected animals served as controls. The timeline of muscle sampling is shown in Fig. 1a .
Muscle transfection
Soleus muscles of anaesthetized rats (3% isoXurane) were transfected essentially as described (see Fig. 1b, c ; Durieux et al. 2009 ). In brief, soleus muscle was surgically exposed and cytomegalovirus-driven expression construct for the chicken FAK homologue, pCMV-FAK (1 mg/ml) or an equivalent amount of empty pCMV-plasmid was injected into the belly portion of the muscle. Plasmid uptake in muscle Wbres was stimulated by three trains of 80 pulses of 100 s duration, each at 100 mA, at two sites lateral to the injection site using needle electrodes with the GET42 generator (EIP Electronique et Informatique du Pilat, Jonzieux, France). The skin and fascia were closed with sutures and the animals transferred to single cages. After a day of reduced cage activity, the behaviour and food intake of transfected rats could not be distinguished to non-transfected animals. Measures of body weight demonstrated that the animals continued to take on weight in the order of 0.3% per day in the week after gene transfer.
In addition, gene electrotransfer was carried out on gastrocnemius medialis muscle. 150 g plasmid in 150 l was injected in the mid portion of the muscle. Subsequently three trains of 100 pulses of 100 s duration, each at 50 mA, were delivered at two locations lateral to the injection site.
"Principles of laboratory animal care" (NIH publication No. 86-23, revised 1985) were followed. The experiments were performed at the Insel-Hospital of Berne, in Switzerland, under approval by the Animal Protection Commission of the Canton Bern, Switzerland and at the Medical School of the University of Birmingham with permission of the Home oYce. The animals were housed in pairs in cages in a care facility with a 12:12-h light/dark cycle at a constant temperature of 22°C and maintained on a diet of standard chow with water ad libitum.
Collection of muscle samples
Soleus and gastrocnemius muscles were extracted from anesthetized rats 1 h and 7 days after transfection. For removal of the soleus muscle, a circumferential incision was made to the skin below the calcaneus. Subsequently, the distal end of the soleus and its attached tendon were exposed with the help of forceps. Bleeding started at this point. The Achilles tendon part of the soleus was grabbed with a bent clamp and cut with a scalpel. The soleus muscle was successively lifted from its bed towards the heel of the knee with the help of the attached clamp. When the 'semitendinous' part became apparent at the proximal end of the soleus muscle, it was cut with a pair of scissors and the muscle was extracted. Gastrocnemius muscles were harvested in separate experiments where the triceps surae (composed of gastrocnemius medialis and lateralis, soleus and plantaris) was removed as a whole. This isolation was achieved by isolating the Achilles tendon as described above for soleus muscle but then the diVerent heads of the muscle-tendons were bundled with a surgical thread before securing them with a clamp. Subsequently, the entire triceps surae was lifted from its bed with the help of a scalpel, trimming oV residuals of attached soft tissue. When the knee heel was apparent, the muscle heads were capped and Sampling of blood serum Blood (0.2 ml) was drawn with a syringe from the 'tissue bed' where the removed, transfected soleus muscle used to reside before the surgery. Another 0.4 ml of blood was drawn from the left ventricle, of euthanized animals and rapidly transposed in heparinized tubes, frozen in liquid nitrogen, and stored at ¡20°C until analysis.
DNA extraction
Deoxyribonucleic acids were extracted with the DNeasy Blood and Tissue Kit (QIAGEN Ltd. QIAGEN House Fleming Way Crawley West Sussex, RH10 9NQ, UK). Blood samples were extracted using the spin-column non-nucleated erythrocytes protocol described in the kit handbook and available at DNeasy website (DNeasy 2006, http://www.qiagen.com). Final sample volume was 100 l. On average, 0.02 g total DNA was isolated per 0.2 ml of serum. Soleus muscle samples were sectioned in a cryostat (Leica) at a thickness of 12 m to aid the lysation process. An estimated volume of 25 mm 3 of sample was used during the protocol for the extraction of DNA from animal tissues. Extracted DNA was stored in ¡20°C freezer.
Polymerase chain reaction
Reverse and forward oligonucleotide primers were designed using Primer Express software (PE Biosystems, Rotkreuz, Switzerland) and Basic Local Alignment Search Tool (BLAST; http://blast.ncbi.nlm.nih.gov/Blast.cgi) to detect unique sequences in the homologous sequence of the respective rat (Genbank AF020777) of chicken FAK homologues (Genbank M86656). The sequence of the two primer pairs is shown in Fig. 2a . Due to the imposed limitations, a chance for primer dimers existed.
PCRs were run on the isolated DNA with FAK-speciWc primers with SYBR Green Master Mix chemistry (Bio-Rad Laboratories Ltd, Hemel Hempstead, UK) on a Xuorescence PCR machine (DNA machine, Bio-RioRad) operated by Opticon 3 monitor software. Reactions were run with 1 l of DNA sample in a Wnal volume of 21 l within 96-well plates based on the Opticon 3 monitor instructions. The PCR protocol comprised an activation step (95°C for 5 min) and 50 cycles of denaturing (95°C for 15 s), annealing (55°C for 1 min) followed by a read of the Xuorescence on the well. This was terminated by melting curve analysis with a protocol rising the temperature in steps of 0.5°C (held 1 s) from 55 to 95°C. The cycle of threshold detection C t was estimated using the Opticon 3 software.
The eYciency of the PCR ampliWcation was quantiWed in titration experiments with pCMV-FAK plasmid and chicken FAK-speciWc primers. The eYciency was assessed from the slope of linear relationship between the input DNA (i.e. plasmid) and the C t of PCR ampliWcation. Plasmid DNA amounts were determined against a standard curve as determined with PCR on a dilution series of pCMV-FAK plasmid. For the spiking experiments, pCMV-FAK plasmid was mixed with DNA sample from blood serum of a non-transfected, control rat at a concentration of 50 femtogram/microliter.
Immunoblotting
Soleus muscles were cryosectioned at 12 m and total homogenate was prepared in modiWed RIPA buVer (1% NP-40, 0.25% deoxycholate, 50 mM Tris HCl, pH 7.4, 1 mM EDTA, 150 mM NaCl, 1 mM NaF, 1 mM PMSF, 1 mM sodium orthovanadate, 1 g/ml leupeptin, 2 g/ml pepstatin, 1 g/ml aprotinin; all reagents were received from Sigma-Aldrich (Dorset, England). Protein concentration was quantiWed with Bicinchoninic acid assay reagents against BSA standard (Pierce, Thermo Fisher ScientiWc, Cramlington, UK). Twenty micrograms of protein were separated by SDS-PAGE, western blotted onto protran nitrocellulose (Schleicher & Schuell BioScience GmbH, Whatman Group Hahnestrasse 3, D-37586 Dassel, Germany) and subjected to immunodetection with p70S6K antibody (C-18, Santa Cruz, CA, USA) as described ). Signal detection was carried out with enhanced chemoluminescence using a Geldoc system that was operated using Quantity One 1-D analysis software 4.6.1 (Bio-Rad Laboratories Ltd, Hemel Hempstead, UK). Signal intensity of the p70S6K bands was determined using the rectangle density mode and background from an empty sample lane was subtracted.
ImmunoXuorescence
Detection of FAK in soleus and gastrocnemius muscle was carried out essentially as described in Klossner et al. (2009) . In brief, 12-m cryosection were incubated with the FAK N-terminal antibody A-17 from rabbit (1:100 dilution, Santa Cruz) and Alexa Fluor 488-coupled secondary anti-rabbit antibody (DAKO, Denmark). Fluorescence and digital phase contrasts were recorded using a TCS SP5 confocal microscope (Leica Microsystem CMS, Mylton Keynes, UK). Mean cross-sectional area of Wbres overexpressing FAK or showing background levels in stained cryosections (=not-overexpressing Wbres) was quantiWed using the macro application of Leica Application Suite (LAS). Towards this end, random images were taken at a 20-fold magniWcation from microscopic Welds of the part in the cross section of pCMV-FAK transfected muscle showing FAK overexpression. FAK-transfected Wbres were identiWed in each image. Then the circumference-as identiWed with the digital phase contrasts-was circled with the quantiWcation tool of LAS to estimate cross-sectional area. For each image, the cross section of clearly demarcated FAK-overexpressing and not-overexpressing muscle Wbres was measured. Raw data were exported for statistical analysis.
Statistics
T tests were carried out to compare the calculated plasmid amounts between the samples. The signiWcance was set to 5%. Results are graphical represented. Figure 1 visualises the methodology employed to transfect soleus muscle of rats with cytomegalovirus-driven expression construct for the chicken FAK homologue, pCMV-FAK. One hundred and Wfty micrograms of plasmid were injected into the exposed muscle which uptake in muscle Wbres was subsequently stimulated by electric pulses (electro gene transfer). The biological eVect of transfection was analyzed 7 days later. Microscopic examination identiWed muscle Wbres which demonstrated sizeably increased expression of FAK protein in the sarcoplasm (Fig. 3a, c) . M. soleus being injected with empty, pCMV-plasmid did Wbres demonstrated on average a 5.5-fold increase in FAK signal intensity (i.e. expression). Their mean cross-sectional area was 52% larger compared to Wbres with baseline FAK levels. Concomitantly, with pCMV-FAK transfection, the protein levels of p70S6K were 2.1-fold increased (Fig. 3e, f) . We transfected the medial portion of gastrocnemius muscle with pCMV-FAK (Fig. 3b) . Transfection eYciency was 4.5% in the targeted muscle portion. The Xuorescent signal for FAK was 73-fold elevated in transfected Wbres.
Results
Muscle transfection
Mean cross-sectional area was 16% larger in muscle Wbres which overexpressed FAK (Fig. 3d) .
Establishing the detection of expression construct
An oligonucleotide pair was designed to detect the expression plasmid pCMV-FAK with PCR-based ampliWcation of a unique nucleotide segment in the exogenous (chicken FAK) DNA sequence of the plasmid (Fig. 2a) . The criteria for the nucleotide pair were that the primers complied with the default settings for SYBR and Taqman biochemistry and would allow separating the exogenic from the endogenous (rat) FAK homologue. 
activated
These setup experiments demonstrated the linear ampliWcation of a speciWc amplicon with a length of 69 bp and a melting temperature of 83.5°C in PCR with pCMV-FAK plasmid DNA (Fig. 2b) . The calculated threshold of detection was estimated to situate at 0.01 femtogram/microliter.
Quantifying plasmid levels in blood of transfected rats
Spiking experiments with DNA from blood serum (='serum DNA') from non-transfected rats showed that the detection of the pCMV-FAK plasmid is feasible (Fig. 4a) . In serum DNA samples from non-transfected rats detection, endogenous background was ampliWed in late cycle of the PCR (C t = 38; data not shown).
We analyzed DNA from blood serum of somatically transfected rats to assess whether the inserted plasmid is detectable with PCR using the chicken FAK-speciWc primers. The plasmid could be detected in serum DNA that had been collected from the muscle bed 1 h after injection of 75 g pCMV-FAK into soleus muscle and surgery (the 'muscle site'; Fig. 5a ). The amplicon was not detected above the background in DNA from blood collected from heart after the same time point of transfection.
In serum DNA that had been collected 7 days after electro gene transfer of soleus muscle, the chicken FAK amplicon could not be detected above background levels seen in non-transfected rats (Fig. 5b) .
A second oligonucleotide primer pair was designed to detect a segment in the endogenous (rat) FAK transcript (Fig. 2a) . Control experiments with this probe showed that endogenous FAK was detectable in serum DNA independent of muscle transfection (Fig. 4e, f) . Fig. 4 PCR detection of exogenous FAK in DNA samples from rats which soleus muscle was transfected with pCMV-FAK. a, b Screen plots of ampliWcation and melting curve for a PCR using chicken FAK primer pairs on serum DNA from a nontransfected rat muscle being spiked with 50 femtogram/ microliter pCMV-FAK. c, d AmpliWcation and melting curves of a PCR of a cDNA sample from pCMV-FAK-transfected rat soleus muscle. e, f PCR using rat FAK-speciWc primers on serum DNA of a rat with pCMV-FAK transfected soleus muscle (dark/red line) and serum DNA of a non-transfected control rat. Note the similar threshold of detection for the endogenous FAK gene transcript Quantifying plasmid in targeted muscle PCR experiments with transfected muscle sample showed that the detection of pCMV-FAK plasmid is feasible in DNA being isolated from soleus muscle 1 h after plasmid injection. Seven days after transfection, detection of the chicken FAK amplicon was retained in cDNA of the soleus muscle being transfected with pCMV-FAK (Figs. 4c, 5b) .
Discussion
Doping represents a major threat for health and interferes with the ideal of fairness in athletic competition. While it is not currently understood to which extent gene doping is currently in use and possibly Wctive (Andersen et al. 2000; Glogger 2008 ), gene doping is on the list of banned interventions without Wrm methods for its detectability being established (Gassmann et al. 2005) . Towards this end, we addressed in a test system for hypertrophy signalling via focal adhesion kinase, whether more recently introduced blood tests would be an option to detect somatic gene therapy with sensitive PCR technology. Our experiments provide novel evidence for anabolic reactions in FAK transfected muscle Wbres and emphasize that detection of exogenous gene sequences is possible on pure DNA that has been isolated with commercial kits from the hypertrophied muscle after transfection. By contrast, detection is not necessarily feasible in DNA being prepared from blood serum. These observations have a number of implications for the biological eVects and diagnostics of gene doping in Sports.
Biochemical and cellular measures of the targeted soleus muscle imply that the enhancement of FAK expression by genetic means elevates cross-sectional area of muscle Wbres and increases in the expression of the phosphotransfer enzyme p70S6kinase (Fig. 3e, f) . This signalling factor correlates strongly with the degree of muscle hypertrophy (Zanchi and Lancha 2008) . We have previously shown that reloading of atrophied soleus muscle increases phosphorylation of p70S6K at regulatory amino acids ). This Wnding indicates that the anabolic eVect of FAK overexpression in the postural muscle under study reXects the ampliWcation of load-induced hypertrophy signalling.
We also targeted gastrocnemius medialis muscle and found that the cross-sectional area of FAK-transfected muscle Wbres was signiWcantly increased compared to non-transfected muscle Wbres as well (+16%, p = 0.04). This degree of hypertrophy is smaller than that seen for transfected soleus (52%) muscle despite heavier elevations in FAK expression levels (73-vs. 7-fold). This discrepancy possibly reXects diVerent Wbre type composition in soleus and gastrocnemius medialis muscle (DeRuiter et al. 1996; Fluck et al. 2002) . Using an antibody that is now understood to detect the activated FAK molecule ), we have shown that FAK activation relates to the recruitment of muscle Wbres types (Fluck et al. 2002) . The predominately slow type motor units in soleus muscle are frequently implicated in load-bearing muscle action with daily movement patterns (i.e. 22-35% of the total time (Hennig and Lomo 1985) . By contrast, the fast type motor units of gastrocnemius muscle are mainly involved in propulsion and thus far less frequently activated in laboratory animals (i.e. <5% of total activity). The comparison of the two muscle types supports the notion that the outcome of recruitment-induced FAK signalling is diVerent in slow and fast type muscle Wbres of anti-gravitational muscle.
Having established the principal feasibility of detecting introduced DNA in serum via ampliWcation of exogenous DNA segment, we were unable to speciWcally amplify the same sequence in serum collected 7 days after the intervention. Similarly, the pCMV-FAK plasmid was not detectable in serum DNA from samples collected from the left ventricle 30 min after plasmid injection in soleus muscle, but when the exogenous FAK sequence was detectable is serum collected close to the site of DNA injection (Fig. 5a) . Meanwhile, the sequence of the endogenous FAK could be ampliWed at a similar level in serum DNA of non-transfected control rat as in serum from rats with pCMV-FAK transfected soleus muscle (Fig. 4e, f) . The positive control experiment indicates that the DNA yield and quality were not limiting factors in our experiments. Our data compare to observations commenting on the narrow time window under which injected DNA can be detected in the circulation (Baumgartner et al. 2009 ). There was minor surgical injury to the transfected soleus muscle. We, therefore, estimate that the pCMV-FAK plasmid that could be detected in serum sampled close to the site of DNA injection originates from the remainder of DNA material which leaked from the electropulsed soleus into the tissue bed or blood normally entering or exiting the soleus muscle. Our observations indicate that dilution eVects in the serum compartment or eventually rapid DNA elimination reduce the chances of detecting gene doping in blood samples collected distant to the site of local genetic treatment.
This relates to a very recent report demonstrating that intramuscularly injected conventional plasmid is rapidly eliminated (Ni et al. 2011 ). Equally we noted that the signal for exogenous FAK was importantly reduced in transfected soleus muscle 7 days after transfection. The Wndings imply that the detection of somatic gene therapy with the employed PCR technology is conWned to a narrow spatialtemporal window after the intervention.
Dilution experiments with pCMV-FAK plasmid showed that the exogenous FAK sequence is not detectable with our PCR setup above background below 0.01 femtogram/microliter reaction mix. PCR experiments with water only imply that the background is explained by the ampliWcation of primer dimers (data not shown). Due to the imposed restrictions for amplicon length, the background PCR product was indistinguishable based on melting temperature to the speciWc product from pCMV-FAK plasmid ampliWcation. We calculate that the threshold level for detection of exogenous FAK by PCR corresponds to a ratio of plasmid to total DNA of 1:10,000 (w/w). Quantitative considerations further indicate that only a minor portion of the original 150 g of the plasmid being injected in soleus muscle (i.e. 1/125,000) is detectable in blood serum. Based on the volumes used to inject plasmid before electropulsing, we estimate that the detection of injected plasmid would not be technically feasible below a concentration an injected amount of 50 g in our rat system. Thus when larger targeted tissues are targeted with similar DNA amounts, it is unlikely detectable with the employed PCR technology.
Conclusions
Our assays in a model system for somatic transgenesis indicate that the option to detect gene doping with conventional PCR is gone 7 days after the DNA intervention. Given this short window of detection, this indicates that a change in current sampling practice is indicated to provide anti-doping panels with the diagnostic power to detect gene doping. This should involve the collection of muscle biopsies within the Wrst week after DNA injection at the suspected site of the genetic intervention.
